BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23821519)

  • 1. MiR-503 regulates osteoclastogenesis via targeting RANK.
    Chen C; Cheng P; Xie H; Zhou HD; Wu XP; Liao EY; Luo XH
    J Bone Miner Res; 2014 Feb; 29(2):338-47. PubMed ID: 23821519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B.
    Cheng P; Chen C; He HB; Hu R; Zhou HD; Xie H; Zhu W; Dai RC; Wu XP; Liao EY; Luo XH
    J Bone Miner Res; 2013 May; 28(5):1180-90. PubMed ID: 23225151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-125a TNF receptor-associated factor 6 to inhibit osteoclastogenesis.
    Guo LJ; Liao L; Yang L; Li Y; Jiang TJ
    Exp Cell Res; 2014 Feb; 321(2):142-52. PubMed ID: 24360988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3).
    Liu T; Qin AP; Liao B; Shao HG; Guo LJ; Xie GQ; Yang L; Jiang TJ
    Bone; 2014 Oct; 67():156-65. PubMed ID: 25019593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases.
    Qu B; Xia X; Yan M; Gong K; Deng S; Huang G; Ma Z; Pan X
    Exp Cell Res; 2015 Oct; 338(1):89-96. PubMed ID: 26216483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation.
    Li Z; Zhang W; Huang Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):273-280. PubMed ID: 29425279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-124 regulates osteoclast differentiation.
    Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
    Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclastic miR-301-b knockout reduces ovariectomy (OVX)-induced bone loss by regulating CYDR/NF-κB signaling pathway.
    Zhu J; Wang H; Liu H
    Biochem Biophys Res Commun; 2020 Aug; 529(1):35-42. PubMed ID: 32560816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced miR-144-3p expression in serum and bone mediates osteoporosis pathogenesis by targeting RANK.
    Wang C; He H; Wang L; Jiang Y; Xu Y
    Biochem Cell Biol; 2018 Oct; 96(5):627-635. PubMed ID: 29334613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
    Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
    Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.
    Wang T; Yin H; Wang J; Li Z; Wei H; Liu Z; Wu Z; Yan W; Liu T; Song D; Yang X; Huang Q; Zhou W; Xiao J
    Oncotarget; 2015 Aug; 6(22):18980-96. PubMed ID: 26053181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.
    Yu FY; Xie CQ; Sun JT; Peng W; Huang XW
    Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
    Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
    J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.
    D'Amelio P; Grimaldi A; Di Bella S; Tamone C; Brianza SZ; Ravazzoli MG; Bernabei P; Cristofaro MA; Pescarmona GP; Isaia G
    J Bone Miner Res; 2008 Mar; 23(3):373-9. PubMed ID: 17967134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.
    D'Amelio P; Grimaldi A; Pescarmona GP; Tamone C; Roato I; Isaia G
    FASEB J; 2005 Mar; 19(3):410-2. PubMed ID: 15611151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-218 Negatively Regulates Osteoclastogenic Differentiation by Repressing the Nuclear Factor-κB Signaling Pathway and Targeting Tumor Necrosis Factor Receptor 1.
    Wang W; Yang L; Zhang D; Gao C; Wu J; Zhu Y; Zhang H
    Cell Physiol Biochem; 2018; 48(1):339-347. PubMed ID: 30016774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-221-5p/Smad3 axis in osteoclastogenesis and its function: Potential therapeutic target for osteoporosis.
    Guo M; Liu N; Guo Z
    Steroids; 2022 Sep; 185():109063. PubMed ID: 35700796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.